SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-612683
Filing Date
2016-06-03
Accepted
2016-06-03 16:30:35
Documents
2
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS GP LLCWARBURG PINCUS PARTNERS, L.P.WARBURG PINCUS PRIVATE EQUITY X, L.P.WARBURG PINCUS X GP L.P.WARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.WPP GP LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 16 d202636dsc13da.htm SC 13D/A 199231
2 EX-20 d202636dex20.htm EX-20 164656
  Complete submission text file 0001193125-16-612683.txt   366059
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 161696074
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK X1 10017
Business Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK X1 10017 212-878-0600
WP X Biologics LLC (Filed by) CIK: 0001575882 (see all company filings)

IRS No.: 422649620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A